Zobrazeno 1 - 10
of 80
pro vyhledávání: '"A D, Erlikh"'
Autor:
N. S. Kostritca, R. M. Rabinovich, R. M. Shakhnovich, I. S. Yavelov, R. G. Gulyan, Yu. K. Rytova, S. N. Tereschenko, A. D. Erlikh, D. V. Pevzner
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 20, Iss 3, Pp 322-330 (2024)
Aim. To analyze the frequency, indications, and outcomes of using glycoprotein IIb/IIIa inhibitors in patients with acute myocardial infarction (AMI) in Russia based on data from a multicenter registry.Material and methods. This work is part of the R
Externí odkaz:
https://doaj.org/article/7b92a445311148e391030de5fc745b45
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 20, Iss 2, Pp 241-248 (2024)
Aim. To analyze demographic, anamnestic and clinical parameters in subjects with coronary artery disease (CAD) or peripheral artery disease (PAD) included in the XATOA study from Russian centers and to compare them with the total population of the in
Externí odkaz:
https://doaj.org/article/5781180f342f4e37a742152f8425ef6a
Autor:
S. A. Boytsov, R. M. Shakhnovich, S. N. Tereshchenko, A. D. Erlikh, D. V. Pevzner, R. G. Gulyan, Yu. K. Rytova, D. V. Khegya, A. A. Khafizov, T. V. Kuzmicheva, A. N. Potapova, E. Yu. Gaskova, N. A. Medvedeva, T. A. Gorozhankina, M. A. Stavtseva, I. V. Romakh
Publikováno v:
Российский кардиологический журнал, Vol 29, Iss 4 (2024)
Aim. To characterize patients with acute non-ST elevation myocardial infarction (NSTEMI) hospitalized in Russian hospitals, study their anamnestic, demographic and clinical characteristics, treatment features and hospital outcomes, as well as compare
Externí odkaz:
https://doaj.org/article/c6faa35c1ca442f79242ae20390fb6b0
Autor:
N. A. Cherepanova, I. S. Mullova, T. V. Pavlova, A. D. Erlikh, O. L. Barbarash, S. A. Berns, E. A. Schmidt, D. V. Duplyakov
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 17, Iss 3, Pp 401-407 (2021)
Aim. To study the features of the use of thrombolytic therapy (TLT) in normotensive patients with pulmonary embolism (PE) in real clinical practice in Russian hospitals.Material and Methods. From 04/1 5/2018 to 04/15/2019 patients hospitalized with a
Externí odkaz:
https://doaj.org/article/e30f051f91bf443fb8630a66976038a4
Autor:
A. D. Erlikh
Publikováno v:
Атеротромбоз, Vol 0, Iss 1, Pp 58-66 (2021)
Review of the latest scientific data and the main provisions of clinical guidelines on the use of anticoagulants and antiaggregants in patients with COVID-19 is presented. A separate part of the paper focuses on the use of prasugrel in this group of
Externí odkaz:
https://doaj.org/article/576743ccdd664cc391e6c84e4b61ddaf
Publikováno v:
Российский кардиологический журнал, Vol 27, Iss 7 (2022)
Aim. To present the clinical characteristics and in-hospital prognosis in patients with pulmonary embolism (PE) and atrial fibrillation (AF).Material and methods. On the initiative of a working group of physicians, the basic principles of an observat
Externí odkaz:
https://doaj.org/article/406a05ae7fda4016bcac0f00bcb13191
Autor:
A. Yu. Lebedeva, O. M. Koteshkova, O. N. Dzhioeva, S. R. Gilyarevsky, T. M. Uskach, M. S. Novikova, Ya. A. Orlova, V. Yu. Kalashnikov, D. V. Privalov, N. A. Ananicheva, M. Yu. Gilyarov, A. D. Erlikh
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 17, Iss 1, Pp 165-168 (2021)
The results of the international multicenter study EMPEROR-REDUCED were reviewed the on-line scientific meeting of Moscow experts on October 30, 2020. Some proposals and recommendations for further study of the cardiovascular and renal effects of emp
Externí odkaz:
https://doaj.org/article/8642d167fac5420cbea6c65fee3a0b3e
Autor:
V. A. Brazhnik, L. O. Minushkina, A. D. Erlikh, E. D. Kosmacheva, M. A. Chichkova, N. R. Khasanov, D. A. Zateyshchikov
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 17, Iss 1, Pp 11-15 (2021)
Aim. To study the prognostic value of the ORACLE risk score for assessing the risk of bleeding in patients with acute coronary syndrome (ACS) undergoing anticoagulants for atrial fibrillation using the combined database of the ORACLE II and RECORD 3
Externí odkaz:
https://doaj.org/article/bf38e9ce645d4340af1c0d6ef63657ef
Publikováno v:
Российский кардиологический журнал, Vol 27, Iss 2S (2022)
Aim. To validate the SIRENA score in assessing the risk of inhospital mortality in patients with pulmonary embolism (PE) in an independent sample.Material and methods. This retrospective, single-center study was based on the Samara Regional Cardiolog
Externí odkaz:
https://doaj.org/article/00120309d63d4db3a0dec054fceb1f6f
Autor:
A. D. Erlikh
Publikováno v:
Атеротромбоз, Vol 0, Iss 1, Pp 9-16 (2020)
The problem of anticoagulant treatment of elderly patients with atrial fibrillation (AF) is very topical for everyday medical practice because, on the one hand, the proportion of elderly patients among those who have AF is constantly increasing, and,
Externí odkaz:
https://doaj.org/article/20d6b80a2c1a4b128654041461b3b406